ClinStar to Host Live Webinar on Including Russia & Eastern Europe for Successful Clinical Trials

SAN FRANCISCO--(BUSINESS WIRE)-- ClinStar, LLC, an established clinical research organization providing clinical research services in the emerging markets of Russia and Eastern Europe to the pharmaceutical and biotechnology industry, announced today that they will host a live webinar on including Russia & Eastern Europe for successful clinical trials.

“The traditional drug development model is evolving as more and more biopharmaceutical organizations look to emerging markets to reduce their clinical research study timelines and clinical development costs through more effective patient recruitment,” says ClinStar CEO David Passov. “For many, the enticement of conducting clinical research studies in emerging markets is over shadowed by the fear of prolonged study start-up times, unknown regulation and logistics requirements and political uncertainty.”

During his live webinar presentation scheduled for Tuesday, January 24, 2012 at 11:00 am ET, Mr. Passov will explore how to effectively navigate these challenges in Russia and parts of Eastern Europe and will demonstrate how these countries are not only effective in rescue trials but should be an integral part of a biopharmaceutical company’s global clinical trial plans.

Mr. Passov will:

  • Discuss characteristics and classification of “Emerging” vs “Emerged” for Eastern European geographies
  • Consider why Russia and parts of Eastern Europe are optimal for conducting clinical research studies compared to other emerging countries
  • Discuss how to successfully navigate cultural differences and regulatory changes in the region in order to achieve expedited approval timelines and patient recruitment
  • Present case studies outlining the operational and opportunity cost savings of global clinical trials in these fast enrolling geographies

About ClinStar, LLC

ClinStar is one of the most prominent clinical research organizations in the emerging markets of Eastern Europe and the Baltics with more than 10 years of expertise in Phase I-IV clinical research studies in multiple therapeutic areas. Headquartered in San Francisco, California, ClinStar manages studies from its offices in Russia, Ukraine and Belarus, with total staff of over 260 people. Its portfolio contains over 130 clinical trials conducted for US and European pharmaceutical and biotechnology companies. More information is available at www.clinstar.com.



CONTACT:

ClinStar, LLC
Heather Newbold, 919-354-3573 ext. 276
[email protected]

KEYWORDS:   United States  Europe  North America  California  Russia

INDUSTRY KEYWORDS:   Health  Biotechnology  Clinical Trials  Pharmaceutical  Other Health

MEDIA:

Logo
 Logo

Suggested Articles

AbbVie snagged the option to license Harpoon’s anti-BCMA multiple myeloma candidate and the duo added up to six new targets to their discovery deal.

In this week's EuroBiotech Report, Bayer's heart failure drug clears phase 3 test, ABPI calls for more U.K. investment and GHO raises €975 million. 

In our EuroBiotech roundup this week, Azeria raises £32 million, Zealand delays phase 3 readout and Galapagos eyes early 2021 IPF futility analysis.